Criterium, Inc.
Clinical trials sponsored by Criterium, Inc., explained in plain language.
-
Blood test could spot hidden breast cancer early and guide Life-Saving treatment
Disease control Recruiting nowThis study is for people with a high-risk type of breast cancer (ER+/HER2-) who have finished initial treatment but still face a chance of the cancer coming back. Researchers will use a simple blood test to look for tiny bits of tumor DNA. If found, participants will be randomly …
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New cocktail of three drugs targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis Phase 2 trial is testing whether a combination of three drugs—tucatinib, eribulin, and trastuzumab—is safe and effective for people with advanced HER2+ breast cancer that has not responded to prior treatments. The study will enroll 30 participants and measure tumor shrinkage…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo aims to fight Hard-to-Treat colorectal cancer
Disease control Recruiting nowThis phase 2 trial tests whether combining two drugs—fruquintinib and TAS-102—works better than fruquintinib alone for people with advanced colorectal cancer that hasn't responded to prior treatments. About 120 adults will be randomly assigned to one of the two groups. The main g…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC